Cypress Capital Group’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$699K Buy
5,776
+2,638
+84% +$319K 0.09% 135
2025
Q1
$350K Sell
3,138
-20
-0.6% -$2.23K 0.05% 167
2024
Q4
$307K Sell
3,158
-300
-9% -$29.2K 0.04% 228
2024
Q3
$398K Buy
3,458
+39
+1% +$4.49K 0.04% 242
2024
Q2
$364K Sell
3,419
-380
-10% -$40.5K 0.04% 236
2024
Q1
$367K Sell
3,799
-105
-3% -$10.2K 0.04% 237
2023
Q4
$394K Sell
3,904
-231
-6% -$23.3K 0.05% 233
2023
Q3
$421K Sell
4,135
-152
-4% -$15.5K 0.06% 230
2023
Q2
$433K Sell
4,287
-71
-2% -$7.17K 0.06% 231
2023
Q1
$401K Sell
4,358
-10
-0.2% -$920 0.06% 223
2022
Q4
$396K Sell
4,368
-13
-0.3% -$1.18K 0.06% 228
2022
Q3
$333K Sell
4,381
-55
-1% -$4.18K 0.06% 220
2022
Q2
$375K Sell
4,436
-30
-0.7% -$2.54K 0.06% 223
2022
Q1
$392K Sell
4,466
-676
-13% -$59.3K 0.05% 236
2021
Q4
$450K Buy
5,142
+66
+1% +$5.78K 0.06% 220
2021
Q3
$415K Buy
5,076
+159
+3% +$13K 0.06% 224
2021
Q2
$448K Hold
4,917
0.06% 216
2021
Q1
$420K Sell
4,917
-5
-0.1% -$427 0.06% 223
2020
Q4
$464K Sell
4,922
-377
-7% -$35.5K 0.07% 204
2020
Q3
$461K Buy
5,299
+601
+13% +$52.3K 0.08% 185
2020
Q2
$411K Buy
4,698
+310
+7% +$27.1K 0.08% 184
2020
Q1
$362K Buy
4,388
+156
+4% +$12.9K 0.08% 149
2019
Q4
$401K Sell
4,232
-10
-0.2% -$948 0.07% 173
2019
Q3
$369K Buy
4,242
+114
+3% +$9.92K 0.07% 182
2019
Q2
$377K Sell
4,128
-32
-0.8% -$2.92K 0.07% 177
2019
Q1
$358K Buy
4,160
+427
+11% +$36.7K 0.07% 186
2018
Q4
$287K Buy
3,733
+346
+10% +$26.6K 0.07% 200
2018
Q3
$261K Buy
+3,387
New +$261K 0.05% 217